Kazakhstan halts talks on AstraZeneca over negativity around this vaccine

AKIPRESS.COM - Kazakhstan has stopped negotiations on buying the AstraZeneca coronavirus vaccine, said Erkhat Iskaliev, chairman of the SK-Pharmacia LLP. During a press conference on Friday, journalists asked Iskaliev how the negotiations with Pfizer, AstraZeneca, Pfizer, Moderna, Johnson & Johnson were going.
"Negotiations are underway with all of them, except for AstraZeneca. Negotiations with them have been terminated because there are too much negative information around this vaccine," Iskaliev responded.
"Negotiations for Pfizer are held constantly, but there are no delivery schedules, and they put forward certain conditions as well," he added.
Four vaccines against coronavirus are currently available in Kazakhstan: Sputnik V in the amount of 10,280,000 doses, QazCovid-in (QazVac) vaccine in the amount of 2 million doses, Hayat-Vax in the amount of 1 million doses, and 500 thousand doses of Coronavac vaccine produced by Sinovac Biotech.
Since February 1, more than 2.1 million people in Kazakhstan have received the first dose of the vaccine, and 1.1 million people have received both doses.